This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
The neuroscience industry is attracting significant investment for developing treatments and new technologies. Companies are working on everything from brain-computer interfaces to drug discovery.
Neuralink leads the field with $1.3B in funding for its brain interface technology. The sector also includes international companies like Spain's INBRAIN Neuroelectronics and drug discovery firm NRG Therapeutics from the UK.
Below is our list of 43 Neuroscience startups worth keeping an eye on.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Neuralink builds implantable brain-computer interfaces that give people with paralysis the ability to control external devices with their thoughts. The neurotechnology company is focused on developing its platform to treat a wide range of neurological disorders.
NRG Therapeutics develops novel drugs for neurodegenerative diseases by targeting mitochondrial health. Their scientific approach focuses on creating small molecule therapies to treat conditions such as Parkinson's disease and ALS.
Biotechnology company Psilera develops treatments for neurological and psychiatric disorders. Their research focuses on creating new psychedelic-based compounds designed to improve mental health without hallucinatory effects.
BrainCo develops brain-computer interface (BCI) technology for applications in the education and wellness sectors. Their hardware and software products are used to help students improve focus and to assist individuals with meditation.
SEVARO delivers teleneurology services that give hospitals on-demand access to expert neurological care. Their platform helps medical teams rapidly diagnose and treat patients with complex and time-sensitive conditions like strokes.
Neurable develops AI tools that translate brain signals into digital commands for brain-computer interfaces. This neurotechnology is designed for applications in augmented and virtual reality, enabling more intuitive human-computer interactions.
INBRAIN Neuroelectronics develops intelligent, graphene-based neural interfaces designed to decode brain signals for therapeutic use. Their brain-computer interface technology offers a less invasive treatment for neurological disorders such as epilepsy and Parkinson's disease.
Alva Health develops a wearable medical device for the remote monitoring of strokes. Their technology is designed to detect neurological events in real-time for at-risk patients, enabling faster medical intervention outside of a clinical setting.
Neurovalens develops non-invasive neurostimulation technology delivered through wearable devices. Their headsets are designed to help regulate functions like sleep, anxiety, and metabolism without drugs or surgery.
Science builds clinical-stage medical technologies that focus on the complex challenges of neuroscience. Their first product, Science Eye, is a visual prosthesis aimed at restoring sight for patients with serious retinal diseases.
Our top picks offer a glimpse into the field, but they are just the beginning. Many more companies are tackling big problems in healthcare and AI, raising over a billion dollars combined.
Some are just getting started with their first funding, while others are growing quickly. Here is a look at the other companies shaping the future of neuroscience.
| Startup | Main Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
| Biotech | 2015 | $134.1M | Venture Round | |
| AI | 2019 | $11M | Seed | |
| Healthcare | 2014 | $198.3M | Venture Round | |
| Healthcare | 2013 | $25M | Convertible Note | |
| AI | 2016 | ₩48B | Corporate Round | |
| Healthcare | 2012 | $340.7M | Venture Round | |
| Healthcare | 2015 | £11.7M | Venture Round | |
| AI | 2013 | €21.2M | Series B | |
| Healthcare | 2010 | €25.7M | Grant | |
| Healthcare | 2019 | €14.1M | Series A | |
| Healthcare | 2016 | $12.6M | Convertible Note | |
| Biotech | 2008 | €26.2M | Series B | |
| AI | 2019 | A$60M | Series C | |
| AI | 2011 | $21.3M | Series A | |
| Healthcare | 2019 | CHF3M | Seed | |
| AI | 2022 | $200k | Pre-Seed | |
| AI | 2023 | $280.8k | Pre-Seed | |
| AI | 2013 | $14.6M | Series B | |
| Manufacturing | 2018 | $6.8M | Grant | |
| Biotech | 2012 | €8.5M | Undisclosed | |
| AI | 2019 | CHF5.9M | Venture Round | |
| Education | 2019 | RUB841M | Venture Round | |
| AI | 2015 | $6.6M | Seed | |
| Healthcare | 2017 | $7.2M | Grant | |
| Biotech | 2012 | €45.3M | Series B | |
| Healthcare | 2017 | €7.2M | Grant | |
| Enterprise | 2019 | €2.4M | Angel | |
| Retail | 2016 | $6.2M | Series A | |
| Mobility | 2018 | €4M | Venture Round | |
| Biotech | 2020 | €95M | Series B | |
| AI | 2015 | $250k | Seed | |
| AI | 2021 | €435k | Pre-Seed | |
| Healthcare | 2025 | €500k | Pre-Seed |
